Company Overview and News

 
Hindalco Industries Limited - Shareholders meeting

20h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
HNDNF HINDALCO 500440

 
Hindalco Industries Limited - Shareholders meeting

22h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
HNDNF HINDALCO 500440

 
Aluminium companies seek safeguard duty on imports to support local production

2018-09-19 thehindubusinessline
Earlier this year, the US slapped higher tariffs on steel and aluminium imported from a handful of countries including India - THE HINDU
HNDNF HINDALCO 500440

1
Acquisitive Indian billionaire says he's hungry for deals

2018-09-19 theedgemarkets
(Sept 19): Kumar Mangalam Birla, the billionaire chairman of the acquisitive Indian conglomerate that bears his name, said he’s hungry for more deals after creating the nation’s biggest mobile-phone operator.
HINDALCO VOD VOD 532538 UCLQF ICLQY ALSD 532822 ULTRACEMCO HNDNF VODPF UCLQY IDEA 500440

 
Metal stocks shine as govt plans to hike steel import duty

2018-09-19 thehindubusinessline
Shares of metal companies jumped after Reuters reported that the government is considering raising the import duty on steel to support rupee. Nifty metal index rose as much 2.1 per cent, its biggest gain in nearly a week
HNDNF 500470 HINDALCO TTST TATASTEEL TATLY 500228 500440 JSWSTEEL

 
Kumar Mangalam Birla scouts for acquisition targets in US, Europe and India

2018-09-19 moneycontrol
Kumar Mangalam Birla, Chairman of the Aditya Birla Group, said at an event he is looking at acquisition targets in the US, Europe and India that will add value to the company.
HNDNF HINDALCO UCLQY IDEA UCLQF ICLQY 532538 ALSD 532822 500440 ULTRACEMCO

 
D-Street Buzz: Nifty metal outperforms led by JSW Steel; Dish TV down 6%, BoB most active

2018-09-19 moneycontrol
The Indian benchmark indices continues to trade on a positive note this Wednesday afternoon with the Nifty50 up 21 points and is trading at 11,300 while the Sensex is trading higher by 53 points at 37,343.
HINDCOPPER KOHINOOR MUTHOOTFIN PGEL 500325 500228 RELIANCE 532617 HNDZY HFCL 533398 NAUKRI 532777 533137 HCL-INSYS DEN 532221 500470 SONATSOFTW RIGD 500179 JSL GAILF BEL RLNIY SBAZ BHQRY HINDALCO 532508 533581 513599 JETAIRWAYS JSWSTEEL 533104 512559 HNDNF 500183 TTST TATASTEEL TATLY GAILY DCMSHRIRAM 500049 GLOBUSSPR 500440 500188 HINDZINC 523367

1
Kumar Mangalam Birla says he is hungry for more deals

2018-09-19 livemint
Mumbai: Kumar Mangalam Birla, the billionaire chairman of the acquisitive Indian conglomerate that bears his name, said he’s hungry for more deals after creating the nation’s biggest mobile-phone operator. His Aditya Birla Group continues to look for targets in the US, Europe and India that make business sense and are likely to add value, the 51-year-old said at Bloomberg’s India Economic Forum on 18 September in Mumbai.
HINDALCO VOD VOD 532538 UCLQF ICLQY ALSD 532822 ULTRACEMCO HNDNF VODPF UCLQY IDEA 500440

 
Hindalco Industries Limited - Shareholders meeting

2018-09-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
HNDNF HINDALCO 500440

 
Hindalco Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-09-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
HNDNF HINDALCO 500440

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...